Infusion of Apomorphine: Long-term Safety Study
Clinical trial NCT02339064 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02339064
- Sponsor
- MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2018-12-01
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.